Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report

Medicine (Baltimore). 2019 Mar;98(9):e14654. doi: 10.1097/MD.0000000000014654.

Abstract

Rationale: Primary squamous cell carcinoma (PSCC) of the breast is one of the least common types of breast cancer. Adjuvant treatment for PSCC remains an unresolved issue.

Patient concerns: We reported a case of a 48-year-old postmenopausal female patients with a 2 × 2.5 cm lump presented with no symptoms.

Diagnoses: This patient was diagnosed as PSCC of the breast. The original tumor and first recurrence exhibited triple negative phenotype, whereas the second recurrence was HER2-positive.

Interventions: A tumorectomy with latissimus dorsi flap reconstruction for the second recurrence was performed followed by targeted therapy with trastuzumab.

Outcomes: The patient had a complete remission, which was sustained over the 25 months of follow-up after the tumorectomy.

Lessons: This is the first reported case in literature of a breast PSCC patient with switched immunohistochemical phenotypes during disease recurrence. Surgical resection with flap reconstruction and targeted therapy successfully treated the recurrence.

Publication types

  • Case Reports

MeSH terms

  • Breast / metabolism
  • Breast Neoplasms / metabolism*
  • Carcinoma, Squamous Cell / metabolism*
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / metabolism*
  • Prognosis
  • Receptor, ErbB-2 / metabolism*

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2